<mediadc-video-embed data-state="{"cms.site.owner":{"_ref":"00000161-3486-d333-a9e9-76c6fbf30000","_type":"00000161-3461-dd66-ab67-fd6b93390000"},"cms.content.publishDate":1656176377568,"cms.content.publishUser":{"_ref":"00000174-20cd-dd98-a5fd-64dfb14c0003","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"cms.content.updateDate":1656176377568,"cms.content.updateUser":{"_ref":"00000174-20cd-dd98-a5fd-64dfb14c0003","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"rawHtml":"
var _bp = _bp||[]; _bp.push({ "div": "Brid_56176232", "obj": {"id":"27789","width":"16","height":"9","video":"1027703"} }); ","_id":"00000181-9bcd-d789-a3f7-9beffa190000","_type":"2f5a8339-a89a-3738-9cd2-3ddf0c8da574"}”>Video EmbedPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works — just days before regulators debate whether to offer people updated booster shots this fall.
